NDC 53002-2540
Cephalexin 250 mg per 5 mL powder, for suspension
On the label: RPK Pharmaceuticals, Inc.. It's repackaged: RPK Pharmaceuticals, Inc. rebottles it from Teva Pharmaceuticals USA, Inc.'s NDC 0093-4177.
Where the pills inside were made
This label doesn't name the factory that makes the drug. Companies don't have to print it on the label. The maker's name is often on the stock bottle your pharmacy used; you can ask the pharmacist. See the plants Teva Pharmaceuticals USA, Inc. names for other drugs.
Repackaging site
- RPK Pharmaceuticals, Inc., Union City, California, United States · relabels it
Recalls
- Aug 24, 2020 · Class II · Teva Pharmaceuticals USA
CGMP deviations; there is a possibility that some bottles in these lots may have the active ingredient above and/or below specification limits.
Lots: Lot #s: a) 30309862A, 30309863A, Exp. 08/2020; 30309928A, 30309929A, Exp. 09/2020; 30310029A, 30310030A, 30310033A, 30310034A, Exp. 10/2020; 30310035A, 30310079A, 30310080A, 30310081A, Exp. 11/2020; 30310134A, 30310135A, Exp. 01/2021; 30310182A, 30310183A, 30310210A, Exp. 02/2021; 30310211A, 30… - Aug 24, 2020 · Class II · Teva Pharmaceuticals USA
Sub-Potent Drug: Out of specification test results for potency (below specification).
Lots: Lot #: 30310638A, Exp. 02/2022
Class I recalls are the most serious; Class III the least. A recall covers specific lots, listed on each recall.
Product details
- Generic drug
- Cephalexin: every company that makes it
- Form
- powder, for suspension
- Strength
- 250 mg per 5 mL
- Approval
- ANDA ANDA062703
- On the market since
- Sep 30, 1990
- Package NDCs
53002-2540-153002-2540-2- Official label
- DailyMed (National Library of Medicine), updated Jun 7, 2023
Got it by mail or from a pharmacy you don't know? Look the pharmacy up on Who Filled My Rx?